Nanalysis Corp.

CALGARY, A0 · Founded 2009 · CIK 0001507204 · Medtech · Public

Compact NMR and MRI analytical instruments

nanalysis.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$15K
1 Form D · Dec 2010
190 months since last filing
Contracts
$411K
6 awards · Defense, Health and Human S, Homeland Security
#396 of 4531 in medtech
Patents
12
7 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$14,703
Federal contractDepartment of Defense · Benchtop Nmr Spectrometer$36,797
Federal contractDepartment of Health and Human Services · NMREADY-60PRO - 60 Mhz Nmr Spectrometer$55,725
Federal contractDepartment of Homeland Security · Purchase Of A Nuclear Magnetic Resonance (nmr) Spectroscopy System For The Hme Laboratory$73,375
Federal contractDepartment of Defense · Spectrometer Pr# 61-0052-19$63,775
Federal contractDepartment of Health and Human Services · Benchtop Nuclear Magnetic Resonance (nmr) Spectrometer$85,750
Federal contractNational Aeronautics and Space Administration · Nmr Spectrometer And Accessories$95,635
Federal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
393BENTEN TECHNOLOGIES, INC.$446K—
394HESPEROS, INC$434K—
395ZMK Medical Technologies, Inc.$422K—
396Nanalysis Corp.$411K$15K
397AMPLIFIDX INC$400K$329K
398Oncobiomix Inc.$400K$250K
399QUANTITATIVE IMAGING SYSTEMS LLC$400K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Mohamed AbousalemDirector
  • Sean KrakiwskyDirector · Executive Officer
  • Garett LeskowitzExecutive Officer
  • Bob SchulzDirector
  • Henry van Der SlootDirector
  • Neil VasantDirector

Patents

USPTO · 7 granted of 12

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.